Cargando…
Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption
BACKGROUND: ABO blood type incompatibility hemolytic disease of newborn (ABO-HDN) and drug-induced immune hemolytic anemia (DIIHA) due to non-immunologic protein adsorption (NIPA) mainly cause extravascular hemolysis. All the reported severe DIIHA were caused by drug-induced antibodies, and rare rep...
Autores principales: | Wu, Yuanjun, Wu, Yong, Yang, Yong, Chen, Baochan, Li, Jianqun, Guo, Ganping, Xiong, Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727536/ https://www.ncbi.nlm.nih.gov/pubmed/35003054 http://dx.doi.org/10.3389/fimmu.2021.698541 |
Ejemplares similares
-
Case Report: Drug-Induced Immune Haemolytic Anaemia Caused by Cefoperazone-Tazobactam/ Sulbactam Combination Therapy
por: Wu, Yuanjun, et al.
Publicado: (2021) -
ABO subgroup incompatibility with severe hemolysis after consecutive allogeneic stem cell transplantations
por: Hecker, Judith S., et al.
Publicado: (2021) -
Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies
por: Wu, Yuanjun, et al.
Publicado: (2021) -
An In Vitro Susceptibility Study of Cefotaxime-Sulbactam on Clinical Bacterial Isolates From Various Regions in India: A Comparison With Ceftriaxone-Sulbactam
por: Gondane, Ajitkumar A, et al.
Publicado: (2023) -
Acute Intravascular Hemolysis Following an ABO Non-Identical Platelet Transfusion: A Case Report and Literature Review
por: Moinuddin, Imran A., et al.
Publicado: (2019)